title: The regulatory process, the Food and Drug Administration, and the silicone breast implant controversy.
authors.affiliation: School of Social Work, University of Maryland, Baltimore, USA.
authors.forename: H A
authors.initials: HA
authors.lastname: Palley
authors.forename: M L
authors.initials: ML
authors.lastname: Palley
mesh_terms: D018427:Breast Implants / Q000009:adverse effects*; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D018795:Device Approval / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D007258:Informed Consent; D010358:Patient Participation; D011057:Politics; D011640:Public Policy; D020034:Silicone Gels / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D014933:Women's Rights
chemical_list: D020034:Silicone Gels